Rogerio Vivaldi is the founder of Sigilon Therapeutics. Based in Cambridge, Massachusetts.
Rogerio Vivaldi Coelho, M.D., M.B.A. served on the Crinetics board of directors since January 2022 and retired as the president, Chief Executive Officer and Director of Sigilon Therapeutics, Inc. in December 2023. He joined the Viatris board of directors in June 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library